NRx Pharmaceuticals (NRXPW) had the highest return in 2020 by a US stock in the Biotechnology Industry, returning 2,951.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
NRx Pharmaceuticals (NRXPW) | 2020 | 2,951.95% |
Novavax (NVAX) | 2020 | 2,694.74% |
Vaxart (VXRT) | 2020 | 1,604.48% |
Clene (CLNNW) | 2020 | 1,563.89% |
Cardiff Oncology (CRDF) | 2020 | 1,327.78% |
Genprex (GNPX) | 2020 | 1,120.59% |
Celldex Therapeutics (CLDX) | 2020 | 682.14% |
Mind Medicine (MNMD) | 2020 | 662.5% |
Immunoprecise Antibodies (IPA) | 2020 | 614.63% |
Seres Therapeutics (MCRB) | 2020 | 606.05% |
Twist Bioscience (TWST) | 2020 | 565.83% |
Greenwich Lifesciences (GLSI) | 2020 | 534.26% |
Altimmune (ALT) | 2020 | 496.83% |
Moderna (MRNA) | 2020 | 433.83% |
Biovie (BIVI) | 2020 | 394.86% |
Curis (CRIS) | 2020 | 384.62% |
Denali Therapeutics (DNLI) | 2020 | 376.99% |
TG Therapeutics (TGTX) | 2020 | 368.23% |
Fate Therapeutics (FATE) | 2020 | 360.64% |
Mersana Therapeutics (MRSN) | 2020 | 358% |
Adaptimmune Therapeutics (ADAP) | 2020 | 341.8% |
Forte Biosciences (FBRX) | 2020 | 341.33% |
GT Biopharma (GTBP) | 2020 | 307.69% |
Arcturus Therapeutics (ARCT) | 2020 | 299.08% |
AquaBounty Technologies (AQB) | 2020 | 298.18% |
